Anti-Synthetase Syndrome clinical trials at UC Irvine
1 research study open to eligible people
Showing trials for
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy
open to eligible people ages 18-75
RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Idiopathic Inflammatory Myopathy
Orange, California and other locations
Our lead scientists for Anti-Synthetase Syndrome research studies include Tahseen Mozaffar, MD.
Last updated: